Yeah still need to run trials and submit all the evidence etc. The designation speeds the approval status up though and there are tax benefits and exclusivity benefits.
Still coming up to speed with all this so DYOR
PharmD
- Forums
- ASX - By Stock
- PAR
- New orphan drug designation
New orphan drug designation, page-8
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
|
|||||
Last
25.5¢ |
Change
-0.010(3.77%) |
Mkt cap ! $89.19M |
Open | High | Low | Value | Volume |
27.0¢ | 27.0¢ | 25.5¢ | $162.7K | 620.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 25008 | 25.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
26.0¢ | 34768 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 25008 | 0.255 |
8 | 215150 | 0.250 |
6 | 109763 | 0.245 |
7 | 91034 | 0.240 |
2 | 54200 | 0.235 |
Price($) | Vol. | No. |
---|---|---|
0.260 | 34768 | 1 |
0.270 | 500 | 1 |
0.275 | 6347 | 2 |
0.290 | 14580 | 3 |
0.295 | 10000 | 2 |
Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |